Concepedia

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group

Jan P. van Meerbeeck, C. Debruyne, Nico van Zandwijk, PE Postmus, MC Pennucci, Frank van Breukelen, Danny Galdermans, Harry J.M. Groen, P. Pinson, M. van Glabbeke,

British Journal of Cancer · 1996 · 85 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +6

Clinical toxicities encountered with paclitaxel (Taxol).

Rowinsky Ek, Eisenhauer Ea, Chaudhry et al. · PubMed · 1993 · 697 citations

Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging

C Boutin, F. Rey, Joanny Gouvernet et al. · Cancer · 1993 · 257 citations

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.

Joan H. Schiller, B. Storer, K D Tutsch et al. · Journal of Clinical Oncology · 1994 · 136 citations

Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

K. Mattson, Giuseppe Giaccone, A. Kirkpatrick et al. · Journal of Clinical Oncology · 1992 · 62 citations